A physician-led program combining GLP-1 receptor agonists (primarily oral semaglutide 14mg) with smartphone-based lifestyle coaching achieved remarkable weight loss outcomes in 708 adults across Singapore's multi-ethnic population. Participants lost an average 12.7% of body weight at 12 months, escalating to 14.7% at 18 months, alongside substantial improvements in blood pressure (-11.5 mmHg systolic), body composition (-8.8% body fat), and glycemic control (-0.6% HbA1c). Higher app engagement correlated with an additional 2.0-2.2% weight loss beyond the baseline intervention effects.
This represents one of the most comprehensive real-world evaluations of hybrid obesity care outside Western populations, addressing a critical evidence gap in Asian healthcare settings. The sustained weight loss trajectory—continuing to improve beyond 12 months—challenges the typical plateau effect seen with most obesity interventions. The digital coaching component appears genuinely additive rather than merely complementary, suggesting technology-enhanced care delivery could democratize access to intensive obesity management. However, the notable ethnic variations in response, particularly reduced efficacy among East Asians, highlight the need for population-specific treatment optimization rather than one-size-fits-all approaches.